|Bid||1.250 x 0|
|Ask||1.290 x 0|
|Day's Range||1.250 - 1.290|
|52 Week Range||0.970 - 1.800|
|Beta (3Y Monthly)||1.00|
|PE Ratio (TTM)||9.37|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.35|
Jan 24 (Reuters) - PW Medtech Group Ltd: * CROSS MARK PURCHASED 28 MILLION SHARES OF CO AT HK$1.21 PER SHARE Source text for Eikon: Further company coverage:
Aug 29 (Reuters) - PW Medtech Group Ltd: * HY PROFIT ATTRIBUTABLE RMB1,587.8 MILLION VERSUS RMB81.7 MILLION * HY REVENUE FROM CONTINUING OPERATIONS RMB143.0 MILLION, UP 9.8% Source text for Eikon: Further ...
Aug 24 (Reuters) - PW Medtech Group Ltd: * CO TO PURCHASE 800,000 CHINA BIOLOGIC PRODUCTS (CBPO) SHARES, AT A PRICE OF US$100.9 PER CBPO SHARE * AGGREGATE PURCHASE PRICE FOR CBPO SHARES SHALL BE $80.72 ...
When PW Medtech Group Limited (HKG:1358) announced its most recent earnings (31 December 2017), I compared it against two factor: its historical earnings track record, and the performance of itsRead More...
Robust, high-growth companies such as MicroPort Scientific are appealing to investors for many reasons. They bring about a strong upside to your portfolio, and less downside risk as opposed toRead More...
Robust, high-growth companies such as Goodbaby International Holdings are appealing to investors for many reasons. They bring about a strong upside to your portfolio, and less downside risk as opposedRead More...